Skip to main content
Top

2008 | OriginalPaper | Hoofdstuk

15 Cardiovasculaire MRI

Auteur : Prof.Dr. A. C. Van Rossum

Gepubliceerd in: Cardiologie

Uitgeverij: Bohn Stafleu van Loghum

share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail

Samenvatting

Wanneer kernspinresonantietomografie, meestal aangeduid met de Angelsaksische term ‘magnetic resonance imaging’ (MRI), wordt toegepast om afbeeldingen te maken van hart en vaten, spreekt men ook wel van ‘cardiovascular magnetic resonance’ (CMR). Hiermee wordt aangegeven dat de techniek specifieke aanpassingen vereist om tegemoet te komen aan de pulsatiele beweging van hart en vaten. CMR werd ongeveer 25 jaar geleden geïntroduceerd voor toepassing in de kliniek, en heeft sindsdien technisch gezien een stormachtige ontwikkeling doorgemaakt. Dit heeft geleid tot een grote stroom klinische onderzoeken, maar het gebruik van CMR in de dagelijkse praktijk is bescheiden gebleven, voornamelijk wegens de relatief hoge kosten en het gebrek aan beschikbare apparatuur en expertise. De laatste jaren is in de cardiologie echter een duidelijke kentering waarneembaar, die samenhangt met de toegenomen mogelijkheden om CMR toe te passen bij de diagnostiek van ischemisch en niet-ischemisch hartfalen.
Literatuur
go back to reference Grothues F, Smith GC, Moon JC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90:29–34.PubMedCrossRef Grothues F, Smith GC, Moon JC, et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol. 2002;90:29–34.PubMedCrossRef
go back to reference Kim R, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–53.PubMedCrossRef Kim R, Wu E, Rafael A, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343:1445–53.PubMedCrossRef
go back to reference Klem I, Heitner JF, Shah DJ, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol. 2006;47:1630–8.PubMedCrossRef Klem I, Heitner JF, Shah DJ, et al. Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging. J Am Coll Cardiol. 2006;47:1630–8.PubMedCrossRef
go back to reference Mahrholdt H, Wagner A, Judd RM, et al. Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J. 2002;23:602–19.PubMedCrossRef Mahrholdt H, Wagner A, Judd RM, et al. Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J. 2002;23:602–19.PubMedCrossRef
go back to reference Mahrholdt H, WagnerA, Judd RM, et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26:1461–74.PubMedCrossRef Mahrholdt H, WagnerA, Judd RM, et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J. 2005;26:1461–74.PubMedCrossRef
go back to reference McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–9.PubMedCrossRef McCrohon JA, Moon JC, Prasad SK, et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation. 2003;108:54–9.PubMedCrossRef
go back to reference Nagel E, Klein C, Paetsch I, et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation. 2003;108:432–7.PubMedCrossRef Nagel E, Klein C, Paetsch I, et al. Magnetic resonance perfusion measurements for the noninvasive detection of coronary artery disease. Circulation. 2003;108:432–7.PubMedCrossRef
go back to reference Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J. 2004;25:1940–65.PubMedCrossRef Pennell DJ, Sechtem UP, Higgins CB, et al. Clinical indications for cardiovascular magnetic resonance (CMR): consensus panel report. Eur Heart J. 2004;25:1940–65.PubMedCrossRef
go back to reference Schwitter J, Nanz D, Kneifel S, et En. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography Circulation. 2001;103:2230–5.PubMedCrossRef Schwitter J, Nanz D, Kneifel S, et En. Assessment of myocardial perfusion in coronary artery disease by magnetic resonance: a comparison with positron emission tomography and coronary angiography Circulation. 2001;103:2230–5.PubMedCrossRef
go back to reference Wahl A, Paetsch I, Gollesch A, et al. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischemia: experience in 1,000 consecutive cases. Eur Heart J. 2004;25:1–7.CrossRef Wahl A, Paetsch I, Gollesch A, et al. Safety and feasibility of high-dose dobutamine-atropine stress cardiovascular magnetic resonance for diagnosis of myocardial ischemia: experience in 1,000 consecutive cases. Eur Heart J. 2004;25:1–7.CrossRef
Metagegevens
Titel
15 Cardiovasculaire MRI
Auteur
Prof.Dr. A. C. Van Rossum
Copyright
2008
Uitgeverij
Bohn Stafleu van Loghum
DOI
https://doi.org/10.1007/978-90-313-7029-0_15